Gadolinium Contrast Dye and Kidney Disease Patients

Gadolinium contrast dye poses a significant health risk to patients with kidney disease.  Gadolinium contrast dye, routinely injected into patients during an MRI, has been linked to Nephrogenic Systemic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD), a rare skin disease, placing thousands of people at risk for serious and permanent injuries and even death.  If you've been injured as a result of having gadolinium injected into your system, contact our gadolinium lawyers immediately for a free consultation.

Gadolinium injections are a routine part of Magnetic Resonance Imaging (MRI) or Magnetic Resonance Angiography (MRA) scans. The gadolinium increases the contrast in the scans and helps doctors spot potential problems more accurately than with the scans by themselves. Unfortunately, some patients with chronic kidney problems have had serious, even lethal, problems following the contrast injections.

The Food and Drug Administration (FDA) issued a Public Health Advisory in December, 2006 about the potential link between Gadolinium and NSF/NFD. 

At this time, the FDA had reports of 90 patients with moderate to end-stage kidney disease who developed Nephrogenic Systemic Fibrosis after an MRI with gadolinium-based contrast. When gadolinium contrast dye is injected into an otherwise-healthy patient, it is generally is eliminated by the kidneys after the examination, and does not cause problems. But those with kidney disease are unable expel gadolinium from their systems. Extended exposure to gadolinium can result in the development of Nephrogenic Systemic Fibrosis (NSF), which is also known as Nephrogrenic Fibrosing Dermopathy (NFD).

NSF and NFD can scar your skin and internal organs, severely restricting joints and movement. Unfortunately, there are no cures for these disorders, and eventually they can result in death.

If you've been injured as a result of gadolinium, you need to contact the gadolinium lawyers at the Simmons firm today for a free legal consultation.

The Simmons firm’s pharmaceutical litigation group has a focused understanding of the complex medical and legal issues involving dangerous drugs and devices.  Attorneys such as our gadolinium lawyers have achieved verdicts and settlements for thousands of clients totaling more than $100 million for our pharmaceutical clients alone.*

We are incredibly proud to have provided a way for our clients to have their day in court and get the compensation they deserve through our gadolinium lawyers and other toxic tort litigation attorneys. At the same time, the positive outcome of these cases has sent a powerful message to drug makers that they are bound to a moral and legal duty to do everything in their power to ensure their drugs are absolutely safe.

^{* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.}